Suchergebnisse - "IFN-β-1a"

PubPharm (14)

1

Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a

enthalten in: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research | 2023

von Nguyen, K. | Olcer, M. | Howlett-Prieto, Q. | +2

2

Study of the effects of interferon β-1a on hospitalized patients with COVID-19 : SBMU Taskforce on the COVIFERON study

enthalten in: Journal of medical virology | 2022

von Fallahzadeh, M. | Pourhoseingholi, M. | Boroujeni, M. | +12

3

Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis : results of 52 weeks of therapy in a randomized, double-blind clinical trial

enthalten in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova | 2022

von Boyko, A. | Boyko, O. | Bakhtiyarova, K. | +15

4

The effect of IFN-β 1a on expression of MDA5 and RIG-1 in multiple sclerosis patients

enthalten in: Biotechnology and applied biochemistry | 2021

von Asadikaram, G. | Meimand, H. | Noroozi, S. | +3

5

Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab : Insights to neuroimmune mechanistic hallmarks

enthalten in: Neurochemistry international | 2020

von Wahdan, S. | El-Derany, M. | Abdel-Maged, A. | +1

ErratumIn: Neurochem Int. 2023 Jun;166:105525. - PMID 37085423

6

Severe Necrosis and Cellulitis Complicating Treatment with Interferon β-1a

enthalten in: Acta neurologica Taiwanica | 2020

von Chang, C. | Lin, C. | Su, J.

7

Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection

enthalten in: The Journal of infectious diseases | 2020

von Clementi, N. | Ferrarese, R. | Criscuolo, E. | +7

8

Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis : Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart®

enthalten in: Advances in therapy | 2019

von Rieckmann, P. | Schwab, M. | Pöhlau, D. | +4

9

Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis : a real-world setting experience

enthalten in: Expert review of clinical pharmacology | 2018

von D'Amico, E. | Patti, F. | Zanghì, A. | +3

10

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration

enthalten in: Metabolism: clinical and experimental | 2017

von La Rocca, C. | Carbone, F. | De Rosa, V. | +15